Literature DB >> 18089822

Induction of apoptosis in plasma cells by B lymphocyte-induced maturation protein-1 knockdown.

Fan-Ru Lin1, Hui-Kai Kuo, Hsia-Yuan Ying, Fu-Hung Yang, Kuo-I Lin.   

Abstract

B lymphocyte-induced maturation protein-1 (Blimp-1) is a transcriptional repressor that plays an important role during plasmacytic differentiation and is expressed in normal and transformed plasma cells. We here investigated the importance of continuous Blimp-1 expression. We found that knockdown of Blimp-1 expression by lentiviral vector-delivered short hairpin RNA causes apoptosis in multiple myeloma cell lines and plasmacytoma cells, indicating that continued expression of Blimp-1 is required for cell survival. We examined the mechanism underlying Blimp-1 knockdown-mediated apoptosis and found that the Blimp-1 knockdown neither reversed the phenotypic markers of plasma cells nor caused cell cycle arrest. Instead, our results show that knockdown of Blimp-1 induced the proapoptotic protein Bim, reduced the antiapoptotic protein Mcl-1, and activated caspase-9 and caspase-3. We further link apoptosis in transformed plasma cells mediated by proteasome inhibitors, the effective therapeutic agent for multiple myeloma patients, with reduced expression of Blimp-1. Lastly, we show that Blimp-1-dependent cell survival may act downstream of IFN regulatory factor 4 (IRF4) because IRF4 knockdown leads to down-regulation of Blimp-1 and apoptosis in multiple myeloma cells and plasmacytoma cells. Together, our data suggest that Blimp-1 ensures the survival of transformed plasma cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18089822     DOI: 10.1158/0008-5472.CAN-07-1868

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  19 in total

1.  Involvement of histone demethylase LSD1 in Blimp-1-mediated gene repression during plasma cell differentiation.

Authors:  Shin-Tang Su; Hsia-Yuan Ying; Yi-Kai Chiu; Fan-Ru Lin; Mei-Yu Chen; Kuo-I Lin
Journal:  Mol Cell Biol       Date:  2009-01-05       Impact factor: 4.272

2.  Plasmacytomagenesis in Eμ-v-abl transgenic mice is accelerated when apoptosis is restrained.

Authors:  Cassandra J Vandenberg; Paul Waring; Andreas Strasser; Suzanne Cory
Journal:  Blood       Date:  2014-07-01       Impact factor: 22.113

3.  Metabolic, Anti-apoptotic and Immune Evasion Strategies of Primary Human Myeloma Cells Indicate Adaptations to Hypoxia.

Authors:  Lukas Janker; Rupert L Mayer; Andrea Bileck; Dominique Kreutz; Johanna C Mader; Kirsten Utpatel; Daniel Heudobler; Hermine Agis; Christopher Gerner; Astrid Slany
Journal:  Mol Cell Proteomics       Date:  2019-02-21       Impact factor: 5.911

4.  MicroRNA 125b inhibition of B cell differentiation in germinal centers.

Authors:  Murali Gururajan; Christopher L Haga; Sabyasachi Das; Chuen-Miin Leu; Daniel Hodson; Sajni Josson; Martin Turner; Max D Cooper
Journal:  Int Immunol       Date:  2010-05-23       Impact factor: 4.823

5.  Antineoplastic effects of liposomal short interfering RNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma.

Authors:  Giovanni Riva; Ivana Lagreca; Adriana Mattiolo; Daniela Belletti; Laura Lignitto; Patrizia Barozzi; Barbara Ruozi; Daniela Vallerini; Chiara Quadrelli; Giorgia Corradini; Fabio Forghieri; Roberto Marasca; Franco Narni; Giovanni Tosi; Flavio Forni; Maria Angela Vandelli; Alberto Amadori; Luigi Chieco-Bianchi; Leonardo Potenza; Maria Luisa Calabrò; Mario Luppi
Journal:  Haematologica       Date:  2015-07-23       Impact factor: 9.941

Review 6.  The Tao of myeloma.

Authors:  Lawrence H Boise; Jonathan L Kaufman; Nizar J Bahlis; Sagar Lonial; Kelvin P Lee
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

7.  Hodgkin disease therapy induced second malignancy susceptibility 6q21 functional variants in roma and hungarian population samples.

Authors:  Dalma Varszegi; Balazs Duga; Bela I Melegh; Katalin Sumegi; Peter Kisfali; Anita Maasz; Bela Melegh
Journal:  Pathol Oncol Res       Date:  2013-12-05       Impact factor: 3.201

8.  Aiolos collaborates with Blimp-1 to regulate the survival of multiple myeloma cells.

Authors:  K-H Hung; S-T Su; C-Y Chen; P-H Hsu; S-Y Huang; W-J Wu; M-J M Chen; H-Y Chen; P-C Wu; F-R Lin; M-D Tsai; K-I Lin
Journal:  Cell Death Differ       Date:  2016-01-29       Impact factor: 15.828

9.  Interplay between SIN3A and STAT3 mediates chromatin conformational changes and GFAP expression during cellular differentiation.

Authors:  Pei-Yi Cheng; Yu-Ping Lin; Ya-Ling Chen; Yi-Ching Lee; Chia-Chen Tai; Yi-Ting Wang; Yu-Ju Chen; Cheng-Fu Kao; John Yu
Journal:  PLoS One       Date:  2011-07-11       Impact factor: 3.240

10.  Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy.

Authors:  Jens G Lohr; Petar Stojanov; Scott L Carter; Peter Cruz-Gordillo; Michael S Lawrence; Daniel Auclair; Carrie Sougnez; Birgit Knoechel; Joshua Gould; Gordon Saksena; Kristian Cibulskis; Aaron McKenna; Michael A Chapman; Ravid Straussman; Joan Levy; Louise M Perkins; Jonathan J Keats; Steven E Schumacher; Mara Rosenberg; Gad Getz; Todd R Golub
Journal:  Cancer Cell       Date:  2014-01-13       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.